Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center.
Eur J Ophthalmol
; 31(1): 10-12, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-791664
ABSTRACT
We report our experience during COVID-19 outbreak for intravitreal injections in patients with maculopathy. We proposed a treatment priority levels and timings; the "High" priority level includes all monocular patients; the "Moderate" is assigned to all patients with an active macular neovascularization; the patients affected by diabetic macular edema or retinal vein occlusion belong to the "Low" class. This organization allowed us to treat the most urgent patients although the injections performed had a 91.7% drop compared to the same period of 2019.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Retinal Diseases
/
Pharmaceutical Preparations
/
Disease Outbreaks
/
Tertiary Care Centers
/
SARS-CoV-2
/
COVID-19
/
Health Priorities
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Eur J Ophthalmol
Journal subject:
Ophthalmology
Year:
2021
Document Type:
Article
Affiliation country:
1120672120962032
Similar
MEDLINE
...
LILACS
LIS